Stay updated on Repeat Intravitreal Injection Safety in Retinitis Pigmentosa Clinical Trial
Sign up to get notified when there's something new on the Repeat Intravitreal Injection Safety in Retinitis Pigmentosa Clinical Trial page.

Latest updates to the Repeat Intravitreal Injection Safety in Retinitis Pigmentosa Clinical Trial page
- Check5 days agoChange DetectedThe record describes a completed Phase 2 study evaluating the safety of repeat jCell injections in adults with retinitis pigmentosa, with study details, results measures, and supporting documents.SummaryDifference46%

- Check12 days agoChange DetectedThe footer revision identifier changes from v3.7.2 to v3.8.0 on a page displaying a 403 Forbidden error.SummaryDifference0.2%

- Check26 days agoChange DetectedA site-wide NIH banner announces the transition from “Artificial Intelligence” to “Super Intelligence,” and the site revision changes from v3.7.1 to v3.7.2. The study record remains unavailable behind a 403 error.SummaryDifference1%

- Check40 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1, while the page continues to display a 403 error.SummaryDifference0.2%

- Check54 days agoChange Detected- The study page now shows a 403 Forbidden error with a simple header and a Home link, indicating that access to the page is blocked. This change reflects that the page content is no longer directly viewable in its current state.SummaryDifference17%

- Check61 days agoChange DetectedThe page shows an updated Revision tag: v3.7.0, replacing the previous v3.6.6. This indicates a newer software revision label is now displayed on the page.SummaryDifference0.1%

Stay in the know with updates to Repeat Intravitreal Injection Safety in Retinitis Pigmentosa Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Repeat Intravitreal Injection Safety in Retinitis Pigmentosa Clinical Trial page.